
An unexpected cellular cross-talk behind ovarian cancer growth has been discovered that can be used as a therapeutic target for future immuno-oncology strategies. The research is particularly interesting because it reveals that the normally anti-tumor gamma delta (gd) T lymphocytes (a type of white blood cells) can also be pro-tumor.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Y9ZMzMypZHM/140810213809.htm